[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360359-105":59,"doc-detail-360359-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-comparative-in-silico-and-in-vitro-analysis-of-antiviral-agents-targeting-estrogen-and-progesterone-receptors-in-breast-cancer-research-findings","A comparative in silico and in vitro analysis of antiviral agents targeting estrogen and progesterone receptors in breast cancer - Research findings","","Nearly 70% of breast cancer cases are hormone receptor-positive (HR+) and remain challenging due to resistance to standard endocrine therapies. This study evaluates repurposed antiviral drugs as modulators of progesterone receptor (PR) and estrogen receptor α (ERα) using hierarchical molecular docking, network pharmacology, MM/GBSA binding free-energy estimation, normal-mode analysis, and 100 ns molecular dynamics simulations. Valganciclovir shows the strongest ERα binding, stable ERα complex energetics, and dose-dependent cytotoxicity in MCF-7 cells, with ERα downregulation and PR-B upregulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-comparative-in-silico-and-in-vitro-analysis-of-antiviral-agents-targeting-estrogen-and-progesterone-receptors-in-breast-cancer-research-findings/360359/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-comparative-in-silico-and-in-vitro-analysis-of-antiviral-agents-targeting-estrogen-and-progesterone-receptors-in-breast-cancer-research-findings/360359.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are estrogen and progesterone receptors important in HR+ breast cancer?","Question",{"text":112,"@type":113},"ERα drives tumor growth by regulating transcription of estrogen-responsive genes, while PR acts as a downstream modulator of ER activity, supporting prognostic and predictive relevance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which antiviral agent showed the best predicted interaction with ERα?",{"text":117,"@type":113},"Valganciclovir exhibited the best binding affinity for ERα among the screened compounds.",{"name":119,"@type":110,"acceptedAnswer":120},"How was receptor-targeting supported experimentally?",{"text":121,"@type":113},"In MCF-7 cells, quantitative real-time PCR showed ERα downregulation (0.76-fold) and PR-B upregulation (1.36-fold) after Valganciclovir treatment, aligning with the predicted targeting mechanism.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360359,1790194504,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nA comparative in silico and in vitro analysis of antiviral agents targeting estrogen and progesterone receptors in breast cancer  \nUma Maheshwari Mugundan1, Venkatesan Saravanan2 &  \nRajanandh Muhasaparur Ganesan1􀀍  \nNearly 70% of all cases of breast cancer are hormone receptor-positive (HR⁺) breast cancer, which continues to pose a significant clinical challenge because of the development of resistance to traditional endocrine therapies. The current study investigates the possibility of repurposing clinically approved antiviral drugs as alternative modulators ofthe progesterone receptor (PR) and estrogen receptor α (ERα) in order to address this. Hierarchical molecular docking, followed by network pharmacology, MM/GBSA free-energy estimation, normal-mode analysis (NMA), and molecular dynamics (MD) simulations, were used to screen 90 antiviral medications that represented 13 pharmacological classes. Valganciclovir had the best binding affinity for ERα (–9.118 kcal mol⁻¹) among the compounds that were screened. It formed hydrophobic contacts with Leu387, Leu525, and Met421, as well as stable hydrogen-bond interactions with the canonical triad residuesGlu353, Arg394, and His524 . With protein RMSD kept within 1 .8–2.2 Å and ligand RMSD kept between 2.0 and 3.5 Å, MD simulations verified complex stability over 100 ns. Valganciclovir–PR interactions, on the other hand, showed greater dynamic fluctuations (ligand RMSD ≈ 3 .0–5.5 Å) and were weaker (–7.673 kcal mol⁻¹). The Valganciclovir–ERα complex’s binding free energy, as determined by MM/ GBSA analysis, was − 44.50 kcal mol⁻¹, supporting strong electrostatic and van der Waals stabilization. In accordance with tighter engagement, NMA showed more conformational restriction upon ERα binding (ΔS = − 9.1 kcal mol⁻¹ K⁻¹) than PR (ΔS = − 7.4 kcal mol⁻¹ K⁻¹). Ten hub genes (GAPDH, AKT1, TNF, EGFR, HIF1A, BCL2, MTOR, GSK3B, MAPK1, and PIK3CA) involved in PI3K/AKT, MAPK, ErbB, and HIF-1 signaling were highlighted among the 142 shared targets between Valganciclovir and genes linked to breast cancer that were found by network pharmacology. In vitro validation in MCF-7 breast cancer cells demonstrated dose-dependent cytotoxicity with an IC₅₀ of 19.43 µg/mL. Quantitative real-time PCR analysis revealed downregulation of ERα (0.76-fold) and upregulation of PR-B (1.36-fold) following treatment, supporting the predicted receptor-targeting mechanism. Collectively, these findings suggest that Valganciclovir may act as a dual-modality modulator—directly stabilizing ERα in an inactive conformation and indirectly attenuating downstream oncogenic signaling—thereby offering a promising scaffold for the development of next-generation endocrine therapeutics in HR⁺ breast cancer.  \nKeywords Antiviral repurposing, Estrogen receptor α, Progesterone receptor, Valganciclovir, Molecular dynamics, Network pharmacology  \nBreast cancer is a highly heterogeneous disease and remains the most commonly diagnosed cancer among women worldwide. In 2022, there were 2.3 million new cases of female breast cancer, and 6,70,000 deaths were  \n1Department of Pharmacy Practice, SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, 603 203 Chengalpattu, Tamil Nadu, India. 2School of Pharmacy, SBV Chennai, Sri Balaji Vidyapeeth (Deemed to be university), Pondicherry 607402, India. 􀀍 email: [mgr@srmist.edu.in](mgr@srmist.edu.in)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nrecorded globally. By 2050, it is expected that the number of new cases and deaths will grow by 38% and 68%, respectively (1) . This alarming rise not only highlights the urgency for better therapeutic strategies but also underscores the importance of optimizing treatment outcomes1. The molecular classification of Breast cancer has been widely studied and commonly grouped into four ca","cbCaihhF5s4oOOST","https://ap.wps.com/l/cbCaihhF5s4oOOST","pdf",3616739,16,"English","# Background\n## Hormone receptor-positive breast cancer and endocrine resistance\n# Computational strategy\n## Docking, network pharmacology, MM/GBSA, NMA, and MD\n# Key results\n## Valganciclovir binding and interaction features\n## Network pharmacology hub genes and target overlap\n# Experimental validation\n## MCF-7 cytotoxicity and qRT-PCR receptor modulation\n# Conclusion\n## Dual-modality modulation and therapeutic implications","[{\"question\":\"Why are estrogen and progesterone receptors important in HR+ breast cancer?\",\"answer\":\"ERα drives tumor growth by regulating transcription of estrogen-responsive genes, while PR acts as a downstream modulator of ER activity, supporting prognostic and predictive relevance.\"},{\"question\":\"Which antiviral agent showed the best predicted interaction with ERα?\",\"answer\":\"Valganciclovir exhibited the best binding affinity for ERα among the screened compounds.\"},{\"question\":\"How was receptor-targeting supported experimentally?\",\"answer\":\"In MCF-7 cells, quantitative real-time PCR showed ERα downregulation (0.76-fold) and PR-B upregulation (1.36-fold) after Valganciclovir treatment, aligning with the predicted targeting mechanism.\"}]","A comparative in silico and in vitro analysis of antiviral agents targeting estrogen and progesterone receptors in breast cancer - Research findings | PDF",1790139780,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a742f9a4c41516641c5423ace22e6ea3.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d72d4bdf7c68e216b3f700689d74a7b.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72794873cbdbdeb77e6e3c8738facd2c.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/986febe8a837bfa9fca415877c3cd863.webp",980,1287]